Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of the National Cancer Institute
|
January 1, 1979
Sensitization in vitro to murine myeloblastic leukemia cells by xenogeneic immune RNA
H D Preisler, S K Jacobs
Clinical and Experimental Immunology
|
September 1, 1978
Migration inhibition of sensitized mouse spleen cells by cell-associated transplantation antigens: effect of method of antigen presentation
S K Jacobs, H D Preisler
Journal of Neurosurgery
|
May 1, 1986
Interleukin-2 and autologous lymphokine-activated killer cells in the treatment of malignant glioma. Preliminary report
S K Jacobs, D J Wilson, P L Kornblith, et al.
Journal of Neurosurgery
|
January 1, 1986
In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytes
S K Jacobs, D J Wilson, P L Kornblith, et al.
Cancer Research
|
April 1, 1986
Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial
S K Jacobs, D J Wilson, P L Kornblith, et al.
Neurosurgery
|
July 1, 1984
Sarcoidosis presenting as an intramedullary spinal cord mass
P W Hitchon, A U Haque, J J Olson, et al.
Iowa Medicine : Journal of the Iowa Medical Society
|
May 1, 1984
CT adapted stereotaxy
P W Hitchon, T T Wilkinson, S K Jacobs, et al.
Brain Research
|
May 7, 1986
Lymphokine activated killer (LAK) cell-mediated lysis of murine glioma: trypsin-chymotrypsin-sensitive glioma protein is responsible for tumor-selective recognition by LAK cells
S K Jacobs, G Melin, B Holcomb, et al.
Journal of Neuro-Oncology
|
January 1, 1987
Lymphokine activated killer (LAK) cell mediated killing of human glioma: effect of pretreating glioma with various membrane modifying agents
S K Jacobs, C W Parham, B Holcomb, et al.
Symposium on Fundamental Cancer Research
|
January 1, 1986
Interleukin 2-activated cytotoxic lymphocytes in cancer therapy
E A Grimm, S K Jacobs, L A Lanza, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of the National Cancer Institute
|
January 1, 1979
Sensitization in vitro to murine myeloblastic leukemia cells by xenogeneic immune RNA
H D Preisler, S K Jacobs
Clinical and Experimental Immunology
|
September 1, 1978
Migration inhibition of sensitized mouse spleen cells by cell-associated transplantation antigens: effect of method of antigen presentation
S K Jacobs, H D Preisler
Journal of Neurosurgery
|
May 1, 1986
Interleukin-2 and autologous lymphokine-activated killer cells in the treatment of malignant glioma. Preliminary report
S K Jacobs, D J Wilson, P L Kornblith, et al.
Journal of Neurosurgery
|
January 1, 1986
In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytes
S K Jacobs, D J Wilson, P L Kornblith, et al.
Cancer Research
|
April 1, 1986
Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial
S K Jacobs, D J Wilson, P L Kornblith, et al.
Neurosurgery
|
July 1, 1984
Sarcoidosis presenting as an intramedullary spinal cord mass
P W Hitchon, A U Haque, J J Olson, et al.
Iowa Medicine : Journal of the Iowa Medical Society
|
May 1, 1984
CT adapted stereotaxy
P W Hitchon, T T Wilkinson, S K Jacobs, et al.
Brain Research
|
May 7, 1986
Lymphokine activated killer (LAK) cell-mediated lysis of murine glioma: trypsin-chymotrypsin-sensitive glioma protein is responsible for tumor-selective recognition by LAK cells
S K Jacobs, G Melin, B Holcomb, et al.
Journal of Neuro-Oncology
|
January 1, 1987
Lymphokine activated killer (LAK) cell mediated killing of human glioma: effect of pretreating glioma with various membrane modifying agents
S K Jacobs, C W Parham, B Holcomb, et al.
Symposium on Fundamental Cancer Research
|
January 1, 1986
Interleukin 2-activated cytotoxic lymphocytes in cancer therapy
E A Grimm, S K Jacobs, L A Lanza, et al.
Page
of 2